Case Study: Killer T-cells therapy for gliosblastoma
In this open-label, first-in-human trial, we have assessed the safety and therapeutic potential of cytomegalovirus-specific (CMV-specific) ACT in an adjuvant setting for…
Case Study: Glioblastoma multiforme pre-therapy
Newro Foundation research team, Prof David Walker, Neurosurgeon and Beth Morrison, Clinical Research & Development Manager, have been working in collaboration with…
Case Study: Recurrent Glioma – an agonising choice of approach
A 48 year old man had been followed in our clinic for approximately 5 years. He had previously been treated at another…